First Imported Case of SARS-CoV-2 Omicron Subvariant BA.5 - Shanghai Municipality, China, May 13, 2022.
Hui Jiang(Chengdu University of Traditional Chinese Medicine), Xi Zhang(Shanghai Municipal Center For Disease Control Prevention), Changcheng Wu(Chinese Center For Disease Control and Prevention), Guizhen Wu(Chinese Center For Disease Control and Prevention), Wenjie Tan(Sinopec (China)), Xuefei Qiao(Songjiang District Central Hospital), Lingyue Yuan(Shanghai Municipal Center For Disease Control Prevention), Xihong Lyu(Songjiang District Central Hospital), Jinyuan Guo(National Institute for Viral Disease Control and Prevention), Min Chen(Central China Normal University), Huanyu Wu(Taiwan Centers for Disease Control), Chaonan Wang, Wenbo Xu(Shenyang Institute of Automation), Zheng Teng(Shanghai Municipal Center For Disease Control Prevention), Hong-You Chen(China Textile Academy), Yaxu Zheng(Shanghai Municipal Center For Disease Control Prevention), Fanghao Fang(Shanghai Municipal Center For Disease Control Prevention)
Cited by 3
Related Papers
A Novel Coronavirus from Patients with Pneumonia in China, 2019
|New England Journal of Medicine|2020|30.5k
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
|The Lancet|2020|12.6k
Human Infection with a Novel Avian-Origin Influenza A (H7N9) Virus
|New England Journal of Medicine|2013|2.4k
Impact on mental health and perceptions of psychological care among medical and nursing staff in Wuhan during the 2019 novel coronavirus disease outbreak: A cross-sectional study
|Brain Behavior and Immunity|2020|1.6k
Disease Prediction by Machine Learning Over Big Data From Healthcare Communities
|IEEE Access|2017|1.3k